Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 5/20 | 0.35 |
| ▸ | CNR2 | P34972 | 5/20 | 0.33 |
| ▸ | MAP4K1 | Q92918 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7745385 | 0.92 | AGTR1 (0.42) | AGTR1AGTR2TBXA2R | |
| SCHEMBL7741465 | 0.91 | AGTR1 (0.36) | AGTR1AGTR2TBXA2RCNR2 | |
| SCHEMBL7745380 | 0.87 | TBXA2R (0.39) | AGTR1AGTR2TBXA2R | |
| SCHEMBL7746494 | 0.86 | MAPT (0.39) | TBXA2R | |
| SCHEMBL7741627 | 0.81 | CNR2 (0.38) | AGTR1AGTR2TBXA2RCNR2MAP4K1 | |
| SCHEMBL7745715 | 0.77 | AGTR1 (0.35) | AGTR1AGTR2TBXA2RCNR2 | |
| SCHEMBL7741615 | 0.76 | CNR2 (0.42) | TBXA2RCNR2 | |
| SCHEMBL7741250 | 0.75 | AGTR1 (0.36) | AGTR1AGTR2TBXA2RCNR2 | |
| SCHEMBL7745955 | 0.73 | TBXA2R (0.41) | TBXA2R | |
| SCHEMBL7745710 | 0.73 | AGTR1 (0.38) | AGTR1AGTR2TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |